For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks ...

Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...

Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation.

Brookfield Asset Management has walked away from an acquisition of Spanish healthcare group Grifols after months of negotiations, sending shares in the short seller target down almost 13 per cent.

The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...

Grifols shares fell as much as 14 per cent after the news was published by Bloomberg, the biggest intra-day decline since Feb ...

Brookfield Asset Management Ltd. abandonó los planes de adquirir Grifols SA, poniendo fin a meses de negociaciones para ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...

Brookfield withdrew its bid for the Spanish pharmaceutical company following a deadlock between the two side over price ...